Skip to main content

Language: English / GĂ idhlig


Chamber and committees

Question reference: S6W-28075

  • Asked by: Stuart McMillan, MSP for Greenock and Inverclyde, Scottish National Party
  • Date lodged: 6 June 2024
  • Current status: Answered by Jenni Minto on 18 June 2024


To ask the Scottish Government what assessment it has made of any benefits to (a) public expenditure and (b) patients’ wellbeing of an increase in the deployment of combined cataract and glaucoma procedures.


The Scottish Government is committed to fully harnessing the potential of research-proven technological and scientific innovations through their rapid national adoption. The Accelerated National Innovation Adoption (ANIA) pathway, led by the Centre for Sustainable Delivery and drawing on the expertise of NHS National Services Scotland, Healthcare Improvement Scotland, Public Health Scotland, and NHS Education for Scotland, has been established to provide a once for Scotland approach to:

• identifying innovations the Scottish Government should consider for national adoption within the NHS through a quarterly horizon scan report

• producing robust value cases around clinical and financial impact

• their national adoption at pace, if approved

The ANIA pathway is governed by an Innovation Design Authority (IDA). This brings together senior Scottish Government and NHS leadership to support improved partnership working, provide system leadership and take joint decisions on the progression of innovations through ANIA stage gates.

Combined cataract and glaucoma procedures will be considered through the ANIA pathway. Scottish Ministers would then consider investment in this programme following any recommendation by the IDA.